REZUROCK can be an inhibitor of UGT1A1. Coadministration of REZUROCK which has a UGT1A1 substrate decreased plasma concentrations in the glucuronide metabolite, which may raise the possibility of adverse reactions associated with sensitive substrates of UGT1A1 The photographs or other third party